153 related articles for article (PubMed ID: 9111154)
1. Effects of combination therapy on the heart.
Messerli FH; Michalewicz L
J Hum Hypertens; 1997 Jan; 11(1):29-33. PubMed ID: 9111154
[TBL] [Abstract][Full Text] [Related]
2. Cardiac effects of combination therapy.
Messerli FH; Michalewicz L
Am J Hypertens; 1997 Jul; 10(7 Pt 2):146S-152S. PubMed ID: 9231891
[TBL] [Abstract][Full Text] [Related]
3. Cardiac effects of combination therapy in hypertension.
Messerli FH; Chander K
J Cardiovasc Pharmacol; 2000; 35 Suppl 3():S17-22. PubMed ID: 10854047
[TBL] [Abstract][Full Text] [Related]
4. Benefits of combination therapy in hypertensive patients with associated coronary artery disease: a subgroup with specific demands.
Morisco C; Lembo G; Sarno D; Argenziano L; Fratta L; Rozza F; Trimarco B
J Cardiovasc Pharmacol; 1998; 31 Suppl 2():S27-33. PubMed ID: 9605599
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
6. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
Thomas GN; Chan P; Tomlinson B
Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
9. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
Dahlöf B
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
[TBL] [Abstract][Full Text] [Related]
11. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
Ovchinnikov AG; Serbul VM; Ageev FT
Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
[TBL] [Abstract][Full Text] [Related]
12. Effects of antihypertensive agents on the left ventricle: clinical implications.
Díez J; González A; López B; Ravassa S; Fortuño MA
Am J Cardiovasc Drugs; 2001; 1(4):263-79. PubMed ID: 14728026
[TBL] [Abstract][Full Text] [Related]
13. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the cardiac effects of antihypertensive agents.
Agabiti-Rosei E
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S42-8. PubMed ID: 7609505
[TBL] [Abstract][Full Text] [Related]
15. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular hypertrophy: should it be reduced?
Messerli FH; Soria F; Aristizabal D
Clin Cardiol; 1993 May; 16(5 Suppl 2):II15-20. PubMed ID: 8504585
[TBL] [Abstract][Full Text] [Related]
17. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
18. Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists.
Messerli FH
Am J Hypertens; 1999 Aug; 12(8 Pt 2):86S-90S. PubMed ID: 10478702
[TBL] [Abstract][Full Text] [Related]
19. Case 3: A patient with systemic hypertension and left ventricular hypertrophy.
Kloner RA; Friedewald VE
Am J Cardiol; 2000 Feb; 85(4):522. PubMed ID: 10728968
[TBL] [Abstract][Full Text] [Related]
20. Regression of left ventricular hypertrophy: are there preferred drugs?
Diamond JA; Phillips RA
Curr Hypertens Rep; 2003 Oct; 5(5):368-71. PubMed ID: 12948428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
